1. Home
  2. NOAH vs OCS Comparison

NOAH vs OCS Comparison

Compare NOAH & OCS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NOAH
  • OCS
  • Stock Information
  • Founded
  • NOAH 2005
  • OCS 2003
  • Country
  • NOAH China
  • OCS Switzerland
  • Employees
  • NOAH N/A
  • OCS N/A
  • Industry
  • NOAH Investment Managers
  • OCS Biotechnology: Pharmaceutical Preparations
  • Sector
  • NOAH Finance
  • OCS Health Care
  • Exchange
  • NOAH Nasdaq
  • OCS Nasdaq
  • Market Cap
  • NOAH 805.9M
  • OCS 956.4M
  • IPO Year
  • NOAH 2010
  • OCS N/A
  • Fundamental
  • Price
  • NOAH $12.08
  • OCS $18.20
  • Analyst Decision
  • NOAH Buy
  • OCS Strong Buy
  • Analyst Count
  • NOAH 2
  • OCS 3
  • Target Price
  • NOAH $12.25
  • OCS $35.33
  • AVG Volume (30 Days)
  • NOAH 76.1K
  • OCS 13.2K
  • Earning Date
  • NOAH 08-27-2025
  • OCS 08-26-2025
  • Dividend Yield
  • NOAH 4.79%
  • OCS N/A
  • EPS Growth
  • NOAH N/A
  • OCS N/A
  • EPS
  • NOAH 0.96
  • OCS N/A
  • Revenue
  • NOAH $353,619,651.00
  • OCS $847,333.00
  • Revenue This Year
  • NOAH N/A
  • OCS $11.49
  • Revenue Next Year
  • NOAH $6.50
  • OCS $1,784.02
  • P/E Ratio
  • NOAH $12.57
  • OCS N/A
  • Revenue Growth
  • NOAH N/A
  • OCS N/A
  • 52 Week Low
  • NOAH $7.33
  • OCS $10.79
  • 52 Week High
  • NOAH $14.90
  • OCS $23.08
  • Technical
  • Relative Strength Index (RSI)
  • NOAH 50.95
  • OCS 50.88
  • Support Level
  • NOAH $11.69
  • OCS $17.27
  • Resistance Level
  • NOAH $12.33
  • OCS $18.57
  • Average True Range (ATR)
  • NOAH 0.29
  • OCS 0.52
  • MACD
  • NOAH -0.07
  • OCS 0.07
  • Stochastic Oscillator
  • NOAH 42.86
  • OCS 72.59

About NOAH Noah Holdings Limited

Noah Holdings Ltd is a wealth management service provider offering comprehensive advisory services on investment and asset allocation, mainly for Mandarin-speaking high-net-worth (HNW) investors. The company's operating segments are Domestic public securities, Domestic asset management, Domestic insurance, Overseas wealth management, Overseas asset management, Overseas insurance and comprehensive services, and Headquarters. Maximum revenue is generated from its Domestic asset management business, which manages private equity funds, real estate equity funds, and private secondary products. The domestic asset management operations focus on managing primary market exits and cross-border ETF products in the secondary market. Geographically, it derives maximum revenue from Mainland China.

About OCS Oculis Holding AG Ordinary shares

Oculis Holding AG is a global biopharmaceutical company purposefully driven to save sight and improve eye care. It includes OCS-01, a topical retinal candidate for diabetic macular edema (DME); OCS-02, a topical biologic candidate for dry eye disease (DED); and OCS-05, a disease modifying candidate for acute optic neuritis (AON) and other neuro-ophtha disorders such as glaucoma, diabetic retinopathy, geographic atrophy, and neurotrophic keratitis.

Share on Social Networks: